Obesity
Obesity(肥胖)
Obesity 相关产品(117)
- GC20007Ginsenoside CKCAS: 39262-14-1纯度: >98.00%
Ginsenoside CK，一种由主要人参皂苷化合物转化而来的次级人参皂苷，比其母体人参皂苷具有更高的生物利用度和溶解性，具有极其重要的意义。
- GC20027(±)5(6)-DiHET MaxSpec® StandardCAS: 213382-49-1纯度: >95.00%
5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases.
- GC26233Docosahexaenoic Acid-d5CAS: 1197205-71-2纯度: >99.00%
Docosahexaenoic acid-d5 (DHA-d5) is intended for use as an internal standard for the quantification of DHA (Item No. 90310) by GC- or LC-MS.
- GC40094all-trans Retinoic Acid-d5纯度: >99.00%
An internal standard for the quantification of all-trans retinoic acid
- GC40218(-)-Epigallocatechin Gallate-d3/d4纯度: >99.00%
An internal standard for the quantification of (–)-epigallocatechin gallate
- GC40713Pinolenic Acid methyl esterCAS: 38406-57-4纯度: >98.00%
A polyunsaturated fatty acid methyl ester
- GC40788Pinolenic Acid ethyl esterCAS: 493015-74-0纯度: >98.00%
A polyunsaturated fatty acid ethyl ester
- GC422913-Hydroxyisobutyrate (sodium salt)CAS: 1219589-99-7纯度: >95.00% / >96.00%
An intermediate in the metabolism of valine
- GC42796Amylin (human) (trifluoroacetate salt)纯度: >95.00%
An antidiabetic peptide that forms amyloid fibrils
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18270 | 22(S)-hydroxy Cholesterol | 22348-64-7 | >95.00% | |
A synthetic oxysterol and LXR modulator | ||||
| GC18387 | Glucocerebrosides | 497155-61-0 | >98.00% | |
A sphingolipid | ||||
| GC18718 | bpV(pic) (potassium hydrate) | 148556-27-8 | >96.00% | |
A PTEN inhibitor | ||||
| GC18762 | Remogliflozin A | 329045-45-6 | - | |
A potent inhibitor of SGLT2 | ||||
| GC20007 | Ginsenoside CK | 39262-14-1 | >98.00% | |
Ginsenoside CK，一种由主要人参皂苷化合物转化而来的次级人参皂苷，比其母体人参皂苷具有更高的生物利用度和溶解性，具有极其重要的意义。 | ||||
| GC20027 | (±)5(6)-DiHET MaxSpec® Standard | 213382-49-1 | >95.00% | |
5(6)-DiHET is a fully racemic version of the enantiomeric forms biosynthesized from 5(6)-EET by epoxide hydrolases. | ||||
| GC26233 | Docosahexaenoic Acid-d5 | 1197205-71-2 | >99.00% | |
Docosahexaenoic acid-d5 (DHA-d5) is intended for use as an internal standard for the quantification of DHA (Item No. 90310) by GC- or LC-MS. | ||||
| GC40024 | Altenusin | 31186-12-6 | >98.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC40094 | all-trans Retinoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of all-trans retinoic acid | ||||
| GC40142 | Lactosylceramides (bovine buttermilk) | 4682-48-8 | >98.00% | |
A sphingolipid | ||||
| GC40218 | (-)-Epigallocatechin Gallate-d3/d4 | - | >99.00% | |
An internal standard for the quantification of (–)-epigallocatechin gallate | ||||
| GC40320 | 12-PAHSA | 1997286-65-3 | >95.00% | |
A FAHFA with anti-diabetic potential | ||||
| GC40384 | CAY10410 | 596104-94-8 | >98.00% | |
A less electrophilic, isosteric analog of 15-deoxy-D12,14-PGJ 2 | ||||
| GC40713 | Pinolenic Acid methyl ester | 38406-57-4 | >98.00% | |
A polyunsaturated fatty acid methyl ester | ||||
| GC40788 | Pinolenic Acid ethyl ester | 493015-74-0 | >98.00% | |
A polyunsaturated fatty acid ethyl ester | ||||
| GC40912 | Glycohyocholic Acid | 32747-08-3 | >98.00% | |
A glycine-conjugated form of hyocholic acid | ||||
| GC41601 | CAY10591 | 839699-72-8 | >98.00% | |
A SIRT1 activator | ||||
| GC41647 | Pinolenic Acid | 16833-54-8 | >98.00% | |
A polyunsaturated fatty acid | ||||
| GC41699 | (Des-octanoyl)-Ghrelin (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||
| GC41873 | 10-Thiastearic Acid | 105099-89-6 | >98.00% | |
A stearoyl CoA desaturase inhibitor | ||||
| GC42291 | 3-Hydroxyisobutyrate (sodium salt) | 1219589-99-7 | >95.00% / >96.00% | |
An intermediate in the metabolism of valine | ||||
| GC42548 | 5-hydroxy Saxagliptin (hydrochloride) | - | >95.00% | |
A major active metabolite of saxagliptin | ||||
| GC42674 | ABD459 | 1047670-51-8 | >95.00% | |
A neutral CB1 antagonist | ||||
| GC42796 | Amylin (human) (trifluoroacetate salt) | - | >95.00% | |
An antidiabetic peptide that forms amyloid fibrils | ||||